1-85276329-G-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003921.5(BCL10):​c.24C>G​(p.Leu8Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,613,778 control chromosomes in the GnomAD database, including 71,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6012 hom., cov: 34)
Exomes 𝑓: 0.30 ( 65901 hom. )

Consequence

BCL10
NM_003921.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.122
Variant links:
Genes affected
BCL10 (HGNC:989): (BCL10 immune signaling adaptor) This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BCL10-AS1 (HGNC:55868): (BCL10 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 1-85276329-G-C is Benign according to our data. Variant chr1-85276329-G-C is described in ClinVar as [Benign]. Clinvar id is 402411.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-85276329-G-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.122 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.308 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCL10NM_003921.5 linkc.24C>G p.Leu8Leu synonymous_variant Exon 1 of 3 ENST00000648566.1 NP_003912.1 O95999

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCL10ENST00000648566.1 linkc.24C>G p.Leu8Leu synonymous_variant Exon 1 of 3 NM_003921.5 ENSP00000498104.1 O95999

Frequencies

GnomAD3 genomes
AF:
0.276
AC:
42027
AN:
152038
Hom.:
6009
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.245
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.236
Gnomad ASJ
AF:
0.334
Gnomad EAS
AF:
0.0749
Gnomad SAS
AF:
0.259
Gnomad FIN
AF:
0.310
Gnomad MID
AF:
0.290
Gnomad NFE
AF:
0.311
Gnomad OTH
AF:
0.288
GnomAD3 exomes
AF:
0.271
AC:
67690
AN:
249826
Hom.:
9922
AF XY:
0.275
AC XY:
37196
AN XY:
135156
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.332
Gnomad EAS exome
AF:
0.0761
Gnomad SAS exome
AF:
0.276
Gnomad FIN exome
AF:
0.316
Gnomad NFE exome
AF:
0.315
Gnomad OTH exome
AF:
0.284
GnomAD4 exome
AF:
0.296
AC:
432591
AN:
1461622
Hom.:
65901
Cov.:
47
AF XY:
0.297
AC XY:
215760
AN XY:
727128
show subpopulations
Gnomad4 AFR exome
AF:
0.241
Gnomad4 AMR exome
AF:
0.196
Gnomad4 ASJ exome
AF:
0.332
Gnomad4 EAS exome
AF:
0.0803
Gnomad4 SAS exome
AF:
0.278
Gnomad4 FIN exome
AF:
0.318
Gnomad4 NFE exome
AF:
0.309
Gnomad4 OTH exome
AF:
0.286
GnomAD4 genome
AF:
0.276
AC:
42055
AN:
152156
Hom.:
6012
Cov.:
34
AF XY:
0.274
AC XY:
20390
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.245
Gnomad4 AMR
AF:
0.235
Gnomad4 ASJ
AF:
0.334
Gnomad4 EAS
AF:
0.0750
Gnomad4 SAS
AF:
0.258
Gnomad4 FIN
AF:
0.310
Gnomad4 NFE
AF:
0.311
Gnomad4 OTH
AF:
0.289
Alfa
AF:
0.310
Hom.:
2434
Bravo
AF:
0.270
Asia WGS
AF:
0.197
AC:
689
AN:
3478
EpiCase
AF:
0.311
EpiControl
AF:
0.314

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Associated with advanced germ cell tumors, unrelated to patient disease -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Immunodeficiency 37 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
10
DANN
Benign
0.83
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11576939; hg19: chr1-85742012; COSMIC: COSV65353426; COSMIC: COSV65353426; API